MiR-1292 Targets FZD4 to Regulate Senescence and Osteogenic Differentiation of Stem Cells in TE/SJ/Mesenchymal Tissue System via the Wnt/β-catenin Pathway
暂无分享,去创建一个
X. Weng | Luchan Deng | Haoying Xu | L. Fan | Junfen Fan | Tao Li | Yanlei Yang | Robert Chunhua Zhao | Jianmin Zhang | Xingyan An
[1] Luchan Deng,et al. MiRNA-10b Reciprocally Stimulates Osteogenesis and Inhibits Adipogenesis Partly through the TGF-β/SMAD2 Signaling Pathway , 2018, Aging and disease.
[2] Hongling Li,et al. Mesenchymal stem cells and immune disorders: from basic science to clinical transition , 2018, Frontiers of Medicine.
[3] G. Barabino,et al. Changes in phenotype and differentiation potential of human mesenchymal stem cells aging in vitro , 2018, Stem Cell Research & Therapy.
[4] Neil D. Theise,et al. Structure and Distribution of an Unrecognized Interstitium in Human Tissues , 2018, Scientific Reports.
[5] K. Kang,et al. miRNAs in stem cell aging and age-related disease , 2017, Mechanisms of Ageing and Development.
[6] J. Davies,et al. Concise Review: Musculoskeletal Stem Cells to Treat Age‐Related Osteoporosis , 2017, Stem cells translational medicine.
[7] Shushan Zhao,et al. miR-139-5p Represses BMSC Osteogenesis via Targeting Wnt/β-Catenin Signaling Pathway. , 2017, DNA and cell biology.
[8] C. Henke,et al. MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation , 2017, The Journal of Biological Chemistry.
[9] Fei Gao,et al. Microvesicles as Potential Biomarkers for the Identification of Senescence in Human Mesenchymal Stem Cells , 2017, Theranostics.
[10] S. Goodman,et al. Inflammation, ageing, and bone regeneration , 2017, Journal of orthopaedic translation.
[11] J. Bao,et al. Senescence of mesenchymal stem cells (Review). , 2017, International journal of molecular medicine.
[12] J. Casal,et al. Combined miRNA profiling and proteomics demonstrates that different miRNAs target a common set of proteins to promote colorectal cancer metastasis , 2017, The Journal of pathology.
[13] Xiao-Dong Su,et al. Optimization of Reference Genes for Normalization of Reverse Transcription Quantitative Real-Time Polymerase Chain Reaction Results in Senescence Study of Mesenchymal Stem Cells. , 2016, Stem cells and development.
[14] X Zhang,et al. Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? , 2016, Cell Death and Differentiation.
[15] Hongling Li,et al. miR-216a rescues dexamethasone suppression of osteogenesis, promotes osteoblast differentiation and enhances bone formation, by regulating c-Cbl-mediated PI3K/AKT pathway , 2015, Cell Death and Differentiation.
[16] Baojie Li,et al. Mesenchymal stem cell aging: Mechanisms and influences on skeletal and non-skeletal tissues , 2015, Experimental biology and medicine.
[17] B. Karadağ,et al. The prognostic value of circulating microRNAs in heart failure: preliminary results from a genome-wide expression study , 2015, Journal of cardiovascular medicine.
[18] L. Deng,et al. Glucocorticoid inhibits cell proliferation in differentiating osteoblasts by microRNA-199a targeting of WNT signaling. , 2015, Journal of molecular endocrinology.
[19] Sunghoon Kim,et al. miR-543 and miR-590-3p regulate human mesenchymal stem cell aging via direct targeting of AIMP3/p18 , 2014, AGE.
[20] A. Levine,et al. MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells , 2014, Oncogene.
[21] Manuel A. González,et al. miR‐335 Correlates with Senescence/Aging in Human Mesenchymal Stem Cells and Inhibits Their Therapeutic Actions Through Inhibition of AP‐1 Activity , 2014, Stem cells.
[22] J. Rossi,et al. The anti-miR21 antagomir, a therapeutic tool for colorectal cancer, has a potential synergistic effect by perturbing an angiogenesis-associated miR30 , 2014, Front. Genet..
[23] A. Kho,et al. MicroRNA-199a is induced in dystrophic muscle and affects WNT signaling, cell proliferation, and myogenic differentiation , 2013, Cell Death and Differentiation.
[24] S. Kauppinen,et al. Treatment of HCV infection by targeting microRNA. , 2013, The New England journal of medicine.
[25] E. Srour,et al. The Changing Balance Between Osteoblastogenesis and Adipogenesis in Aging and its Impact on Hematopoiesis , 2013, Current Osteoporosis Reports.
[26] G. Duda,et al. Functional Comparison of Chronological and In Vitro Aging: Differential Role of the Cytoskeleton and Mitochondria in Mesenchymal Stromal Cells , 2012, PloS one.
[27] J. Nathans,et al. Norrin/Frizzled4 Signaling in Retinal Vascular Development and Blood Brain Barrier Plasticity , 2012, Cell.
[28] Sun Young Lee,et al. miR-486-5p induces replicative senescence of human adipose tissue-derived mesenchymal stem cells and its expression is controlled by high glucose. , 2012, Stem cells and development.
[29] Yu Suk Choi,et al. Age-related alterations in mesenchymal stem cells related to shift in differentiation from osteogenic to adipogenic potential: Implication to age-associated bone diseases and defects , 2012, Mechanisms of Ageing and Development.
[30] G. Stein,et al. MicroRNA control of bone formation and homeostasis , 2012, Nature Reviews Endocrinology.
[31] T. Wen,et al. MicroRNAs as a novel cellular senescence regulator , 2012, Ageing Research Reviews.
[32] A. Dopazo,et al. miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells , 2011, Cell Death and Differentiation.
[33] T. Rachner,et al. Osteoporosis: now and the future , 2011, The Lancet.
[34] P. Leprince,et al. The Wnt/beta‐catenin pathway is activated during advanced arterial aging in humans , 2011, Aging cell.
[35] R. Knight,et al. MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines , 2011, Cell cycle.
[36] Carmen Koch,et al. How to track cellular aging of mesenchymal stromal cells? , 2010, Aging.
[37] Wei Liu,et al. A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. , 2009, The Journal of clinical investigation.
[38] M. Valenti,et al. Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis. , 2009, Arthritis and rheumatism.
[39] Ichiro Takada,et al. Wnt and PPARγ signaling in osteoblastogenesis and adipogenesis , 2009, Nature Reviews Rheumatology.
[40] E. Sontheimer,et al. Origins and Mechanisms of miRNAs and siRNAs , 2009, Cell.
[41] D. Bartel. MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.
[42] Cun-Yu Wang,et al. Wnt signaling and skeletal development. , 2008, Cellular signalling.
[43] E. Jones,et al. Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies , 2008, Mechanisms of Ageing and Development.
[44] F. Luciani,et al. Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. , 2007, Genes & development.
[45] W. Stanford,et al. Longitudinal Analysis of Mesenchymal Progenitors and Bone Quality in the Stem Cell Antigen‐1–Null Osteoporotic Mouse , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[46] Andrea Giustina,et al. Mechanisms of anabolic therapies for osteoporosis. , 2007, The New England journal of medicine.
[47] C. Kuo,et al. Augmented Wnt Signaling in a Mammalian Model of Accelerated Aging , 2007, Science.
[48] Yvonne Tay,et al. A Pattern-Based Method for the Identification of MicroRNA Binding Sites and Their Corresponding Heteroduplexes , 2006, Cell.
[49] O. MacDougald,et al. Regulation of bone mass by Wnt signaling. , 2006, The Journal of clinical investigation.
[50] Techung Lee,et al. Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture , 2005, Journal of cellular physiology.
[51] Q. Han,et al. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. , 2005, Biochemical and biophysical research communications.
[52] Hendrik C Korswagen,et al. Functional Interaction Between ß-Catenin and FOXO in Oxidative Stress Signaling , 2005, Science.
[53] R. Nusse,et al. The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.
[54] V. Ambros. The functions of animal microRNAs , 2004, Nature.
[55] Ajamete Kaykas,et al. WNT and β-catenin signalling: diseases and therapies , 2004, Nature Reviews Genetics.
[56] Masashi Narita,et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways , 2003, The EMBO journal.
[57] Gideon A. Rodan,et al. Control of osteoblast function and regulation of bone mass , 2003, Nature.
[58] David L. Lacey,et al. Osteoclast differentiation and activation , 2003, Nature.
[59] Jean Y. J. Wang,et al. Coordinated regulation of life and death by RB , 2003, Nature Reviews Cancer.
[60] J. Manfredi,et al. Multiple roles of the tumor suppressor p53 , 2002, Current opinion in oncology.
[61] J. Glowacki,et al. Age‐related decline in the osteogenic potential of human bone marrow cells cultured in three‐dimensional collagen sponges , 2001, Journal of cellular biochemistry.
[62] William C. Skarnes,et al. An LDL-receptor-related protein mediates Wnt signalling in mice , 2000, Nature.
[63] Yoichi Kato,et al. LDL-receptor-related proteins in Wnt signal transduction , 2000, Nature.
[64] M. Long,et al. Three-dimensional cellular development is essential for ex vivo formation of human bone , 2000, Nature Biotechnology.
[65] M. Mastrogiacomo,et al. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. , 2000, Experimental hematology.
[66] J. Rodríguez,et al. Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cells dynamics , 1999, Journal of cellular biochemistry.
[67] G. Karsenty,et al. Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.
[68] Jeremy Nathans,et al. A new member of the frizzled family from Drosophila functions as a Wingless receptor , 1996, Nature.
[69] D. Dufrane. Impact of age on human adipose stem cells for bone tissue engineering. , 2017, Cell transplantation.
[70] M. Kassem,et al. Assessment of bone formation capacity using in vivo transplantation assays: procedure and tissue analysis. , 2008, Methods in molecular biology.
[71] F. Dagnaes-hansen,et al. Aged Human Bone Marrow Stromal Cells Maintaining Bone Forming Capacity in vivo Evaluated Using an Improved Method of Visualization , 2004, Biogerontology.
[72] Randall T Moon,et al. WNT and beta-catenin signalling: diseases and therapies. , 2004, Nature reviews. Genetics.
[73] N. Endo,et al. Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation , 1999, Journal of Bone and Mineral Metabolism.
[74] H. Minne. Osteoporosis in the elderly , 1989, Zeitschrift fur Rheumatologie.